Literature DB >> 10770725

Practice guidelines for the treatment of fungal infections. For the Mycoses Study Group. Infectious Diseases Society of America.

J D Sobel1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10770725     DOI: 10.1086/313746

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  10 in total

1.  Value of measuring serum procalcitonin, C-reactive protein, and mannan antigens to distinguish fungal from bacterial infections.

Authors:  G L Petrikkos; S A Christofilopoulou; N K Tentolouris; E A Charvalos; C J Kosmidis; G L Daikos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-04       Impact factor: 3.267

Review 2.  Combination treatment of invasive fungal infections.

Authors:  Pranab K Mukherjee; Daniel J Sheehan; Christopher A Hitchcock; Mahmoud A Ghannoum
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

3.  Extracorporeal membrane oxygenation (ECMO) for severe acute respiratory distress syndrome (ARDS) in fulminant blastomycosis in Germany.

Authors:  Markus Resch; Katrin Kurz; Wulf Schneider-Brachert; Kathrin Tintelnot; Christoph Birner; Thomas Schichtl; Matthias Lubnow; Christina Hart; Clemens Jilek; Simone Bertz; Michael Hilker; Günter A J Riegger; Andreas Luchner; Thomas Müller
Journal:  BMJ Case Rep       Date:  2009-06-28

Review 4.  Caspofungin: a review of its use in the treatment of fungal infections.

Authors:  Paul L McCormack; Caroline M Perry
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Targeted high lung concentrations of itraconazole using nebulized dispersions in a murine model.

Authors:  Jason T McConville; Kirk A Overhoff; Prapasri Sinswat; Jason M Vaughn; Bradi L Frei; David S Burgess; Robert L Talbert; Jay I Peters; Keith P Johnston; Robert O Williams
Journal:  Pharm Res       Date:  2006-05-05       Impact factor: 4.200

6.  Empiric antifungal therapy in neutropenic cancer patients.

Authors:  Coleman Rotstein
Journal:  Curr Infect Dis Rep       Date:  2006-01       Impact factor: 3.725

Review 7.  [Therapy of severe fungal infections].

Authors:  M Battegay; U Flückiger
Journal:  Internist (Berl)       Date:  2003-12       Impact factor: 0.743

Review 8.  Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology.

Authors:  Jamie D Croxtall; Greg L Plosker
Journal:  Drugs       Date:  2009       Impact factor: 9.546

9.  Anidulafungin.

Authors:  David Murdoch; Greg L Plosker
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  Characterization of the vaginal micro- and mycobiome in asymptomatic reproductive-age Estonian women.

Authors:  Tiina Drell; Triin Lillsaar; Lea Tummeleht; Jaak Simm; Anu Aaspõllu; Edda Väin; Ivo Saarma; Andres Salumets; Gilbert G G Donders; Madis Metsis
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.